Evaluation of a Virtual Reality Tool for Identifying the Cognitive Functions of the Right Hemisphere in Patients With Brain Damage -TANGO (TANGO)

July 25, 2025 updated by: University Hospital, Angers
Evaluate the diagnostic performance of a virtual reality application to detect the presence of cognitive impairment of the non-dominant hemisphere in patients with brain damage

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Angers, France, 49000
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Indication for brain lesion located in the right hemisphere surgery
  • Major patient
  • Karnofsky ≥ 70

Exclusion Criteria:

  • Person with aphasia
  • Person with visual problems
  • Person with a contraindication to MRI
  • Person unable to carry out the tests planned in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: single arm
Diagnostic test: VIRTUAL REALITY application
application on virtual reality headset

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Performance of the virtual reality application compared to classic cognitive tests batery for the detection of cognitive deficit
Time Frame: from surgery to 3 months after surgery
from surgery to 3 months after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Performance of the virtual reality application compared with conventional cognitive tests used to detect visual-spatial attention disorders
Time Frame: from surgery to 3 months after surgery
from surgery to 3 months after surgery
Performance of the virtual reality application compared with conventional cognitive tests used to detect facial emotion recognition disorders
Time Frame: from surgery to 3 months after surgery
from surgery to 3 months after surgery
Performance of the virtual reality application compared with conventional cognitive tests, used to detect spatial attention disorders or the presence of facial emotion recognition disorders depending respectively on the location or type of facial emotion
Time Frame: from surgery to 3 months after surgery
from surgery to 3 months after surgery
Study the reproducibility of the virtual reality application for detecting the presence of cognitive function disorders
Time Frame: from surgery to 3 months after surgery
from surgery to 3 months after surgery
Study the correlation between visuo-spatial and facial emotion recognition deficits and possible tractographic changes
Time Frame: from surgery to 3 months after surgery
from surgery to 3 months after surgery
Study the association between the presence of cognitive function deficits and the presence of behavioral disorders or health-related quality of life
Time Frame: from surgery to 3 months after surgery
from surgery to 3 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Angers

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2020

Primary Completion (Actual)

February 4, 2025

Study Completion (Actual)

May 5, 2025

Study Registration Dates

First Submitted

February 14, 2020

First Submitted That Met QC Criteria

February 25, 2020

First Posted (Actual)

February 28, 2020

Study Record Updates

Last Update Posted (Actual)

July 30, 2025

Last Update Submitted That Met QC Criteria

July 25, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020-A00074-35

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Virtual Reality

Clinical Trials on VIRTUAL REALITY application

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe